Christopher P. Stewart is CFO at Bionano Genomics, Inc. (BNGO). They have made 1 open-market trade across 1 company since 2023, most recently 2023-05-12.
CIK 0001822991
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $34K since 2023, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BNGO | 281,373 | $357K |
Shares reported on the most recent Form 4, priced at the 2023-05-16 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BNGO | BUY | 2023-05-12 | 2023-05-16 | $0.67 | $34K | -3.4% | +12.1% | -47.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.